KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:开放图源暂不可得 入排置信度 0.95

Long-term Results from the LEA Randomized Trial: Extended Versus Standard Lymph Node Dissection in Patients with Bladder Cancer Undergoing Radical Cystectomy.

Matthias Michael Heck, Jan Lehmann, Thomas Amiel, Herbert Rübben, Peter Albers, Johannes M Wolff, Detlef Frohneberg, Patrick de Geeter, Axel Heidenreich, Tilman Kälble, Michael Stöckle, Thomas Schnöller, Arnulf Stenzl, Markus Müller, Michael Truss, Stephan Roth, Uwe-Bernd Liehr, Joachim Leißner, Thomas Bregenzer, Heidrun Rexer, Margitta Retz, Jürgen E Gschwend

Eur Urol 88(6) 566-570

PMID40967930
PMCID-
DOI10.1016/j.eururo.2025.09.001
发表日期2025-09-18
入排依据:This is a randomized, phase 3 oncology trial with time-to-event efficacy endpoints (RFS, OS, CSS) and Kaplan-Meier/HR results. However, it compares two surgical techniques (lymph node dissection extent) and does not contain a drug-containing intervention as required.
疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。
摘要

摘要

The extent of lymph node dissection (LND) at the time of radical cystectomy (RC) for bladder cancer (BC) may affect oncologic outcomes. We present updated long-term data from a prospective, multicenter, phase 3 trial involving patients with locally resectable, high-risk T1 grade 3 or muscle-invasive urothelial BC (T2-T4a M0) without neoadjuvant treatment (trial LEA AUO AB 25/02; NCT01215071). A total of 401 patients were randomly assigned 1:1 to either standard LND (sLND: obturator, internal, and external iliac nodes) or extended LND (eLND), which also included the deep obturator, common iliac, presacral, paracaval, interaortocaval, and para-aortic nodes up to the inferior mesenteric artery. Median follow-up for patients alive without disease recurrence was 58.4 mo. The primary endpoint was recurrence-free survival (RFS). Overall survival (OS) and cancer-specific survival (CSS) were secondary endpoints. eLND failed to show superiority over sLND for RFS (5-yr rate: 68% vs 60%; hazard ratio [HR] 0.80, 95% confidence interval [CI] 0.56-1.14; p = 0.2) and OS (5-yr rate: 57% vs 51%; HR 0.84, 95% CI 0.64-1.12; p = 0.2). The CSS rate was significantly higher in the eLND arm (5-yr rate: 76% vs 65%; HR 0.65, 95% CI 0.43-0.96; p = 0.031), which is clinically meaningful. With long-term follow-up, this randomized controlled trial remains negative for the primary endpoint of RFS, but was positive for CSS. Therefore, meticulous LND using at least a standard template remains the recommended surgical approach for patients undergoing RC for BC.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。